Zosyn in Galaxy Containers is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. The primary component is Tazobactam Sodium; Piperacillin Sodium.
Product ID | 0206-8861_03e17f00-a22b-4954-be11-1cc7f40f2e57 |
NDC | 0206-8861 |
Product Type | Human Prescription Drug |
Proprietary Name | Zosyn in Galaxy Containers |
Generic Name | Tazobactam Sodium And Piperacillin Sodium |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1998-03-01 |
Marketing Category | NDA / NDA |
Application Number | NDA050750 |
Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
Substance Name | TAZOBACTAM SODIUM; PIPERACILLIN SODIUM |
Active Ingredient Strength | 375 mg/50mL; g/50mL |
Pharm Classes | beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC],Penicillin-class Antibacterial [EPC],Penicillins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1998-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050750 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1998-03-01 |
Marketing Category | NDA |
Application Number | NDA050750 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1998-03-01 |
Ingredient | Strength |
---|---|
TAZOBACTAM SODIUM | 375 mg/50mL |
SPL SET ID: | e103a5e4-1d0b-4e1f-c69b-774f6ab70df1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0206-8860 | Zosyn | TAZOBACTAM SODIUM and PIPERACILLIN SODIUM |
0206-8861 | Zosyn | TAZOBACTAM SODIUM and PIPERACILLIN SODIUM |
0206-8862 | Zosyn | TAZOBACTAM SODIUM and PIPERACILLIN SODIUM |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZOSYN 74400770 1915777 Live/Registered |
WYETH HOLDINGS LLC 1993-06-11 |